The bill amends the Public Health Code to specifically address the controlled substance xylazine, updating key definitions to include it alongside other controlled substances in terms such as "administer," "deliver," "dispense," and "manufacture." It introduces the concept of "licit use" of xylazine, detailing acceptable practices in compliance with federal regulations, and establishes penalties for illicit use, classifying it as a felony with potential imprisonment of up to five years or fines up to $15,000. The bill also emphasizes the importance of medical assistance in overdose situations, providing protections for individuals seeking help, ensuring they are not prosecuted for possession of controlled substances, including xylazine.

Additionally, the bill introduces amendments related to drug-related offenses, allowing individuals to petition for resentencing if their probation officers do not recommend discharge, and clarifying the definition of "drug overdose" to encompass conditions resulting from controlled substances like xylazine. It establishes stricter penalties for the fraudulent acquisition of controlled substances, particularly concerning xylazine, and expands the definition of "drug paraphernalia" to include items designed for its use. The bill also prohibits the sale of objects intended for inhaling nitrous oxide or drug paraphernalia, requiring prior written notice before arrests for such violations, with increased penalties for selling to minors. Overall, the amendments aim to enhance regulation and address the public health concerns associated with xylazine and drug misuse.

Statutes affected:
House Introduced Bill: 333.7103